Peutz-Jeghers syndrome differential diagnosis: Difference between revisions
Hamid Qazi (talk | contribs) |
Hamid Qazi (talk | contribs) |
||
Line 19: | Line 19: | ||
! rowspan="2" |Diseases | ! rowspan="2" |Diseases | ||
! colspan="4" |History and Symptoms | ! colspan="4" |History and Symptoms | ||
! colspan=" | ! colspan="3" |Physical Examination | ||
! colspan="4" |Laboratory Findings | ! colspan="4" |Laboratory Findings | ||
! rowspan="2" |Other Findings | ! rowspan="2" |Other Findings | ||
Line 27: | Line 27: | ||
!Hyperpigmentation | !Hyperpigmentation | ||
!Fatigue | !Fatigue | ||
!Abdominal | !Abdominal Tenderness | ||
!Hyperpigmentation | !Hyperpigmentation | ||
!Anemia | !Anemia | ||
!Gene(s) | !Gene(s) | ||
!Sertoli Cell Tumors | !Sertoli Cell Tumors | ||
Line 41: | Line 40: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |SMAD4 | | style="background: #F5F5F5; padding: 5px;" |SMAD4 | ||
Line 64: | Line 62: | ||
Facial+ | Facial+ | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" |Axillary+ | | style="background: #F5F5F5; padding: 5px;" |Axillary+ | ||
Line 71: | Line 69: | ||
Facial+ | Facial+ | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |PTEN | | style="background: #F5F5F5; padding: 5px;" |PTEN | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 87: | Line 84: | ||
Mucosal+ | Mucosal+ | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" |Facial+ | | style="background: #F5F5F5; padding: 5px;" |Facial+ | ||
Mucosal+ | Mucosal+ | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |PRKAR1A | | style="background: #F5F5F5; padding: 5px;" |PRKAR1A | ||
| style="background: #F5F5F5; padding: 5px;" | ++ | | style="background: #F5F5F5; padding: 5px;" | ++ | ||
Line 104: | Line 100: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+/- | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |APC | | style="background: #F5F5F5; padding: 5px;" |APC | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 119: | Line 114: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+/- | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |MLH1 | | style="background: #F5F5F5; padding: 5px;" |MLH1 | ||
Line 139: | Line 133: | ||
| style="background: #F5F5F5; padding: 5px;" |Sebaceous adenoma | | style="background: #F5F5F5; padding: 5px;" |Sebaceous adenoma | ||
|} | |} | ||
<small><small> | <small><small> |
Revision as of 16:54, 20 December 2017
Peutz-Jeghers syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Peutz-Jeghers syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Peutz-Jeghers syndrome differential diagnosis |
Risk calculators and risk factors for Peutz-Jeghers syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Peutz-Jeghers syndrome must be differentiated from other diseases that cause hamartomatous polyps and mucocutaneous pigmentation, such as Cowden syndrome, Bannayan–Riley–Ruvalcaba syndrome, juvenile polyposis, and McCune-Albright syndrome.
Differentiating Peutz-Jeghers Syndrome from other Diseases
Peutz-Jeghers syndrome must be differentiated from the following diseases:[1]
- Cowden syndrome
- Cronkhite-Canada syndrome
- Bannayan–Riley–Ruvalcaba syndrome
- Juvenile polyposis
- McCune-Albright syndrome
Differential diagnosis according to polys:
Diseases | History and Symptoms | Physical Examination | Laboratory Findings | Other Findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Abdominal Pain | Rectal Bleeding | Hyperpigmentation | Fatigue | Abdominal Tenderness | Hyperpigmentation | Anemia | Gene(s) | Sertoli Cell Tumors | Gastrointestinal Tumors | Cancers | ||
Juvenile Polyposis Syndrome | + | - | + | - | - | - | SMAD4
BMPR1A |
- | Adenoma+
Hamartoma+++ |
Colon | ||
Cowden Syndrome | - | - | Axillary+
Inguinal+ Facial+ |
- | - | Axillary+
Inguinal+ Facial+ |
- | PTEN | - | Adenoma+
Hamartoma+++ |
Breast, Thyroid, Endometrium | Trichilemmoma, skin hamartoma, hyperplastic polyps, macrocephaly, breast fibrosis |
Carney Syndrome | - | - | Facial+
Mucosal+ |
- | - | Facial+
Mucosal+ |
- | PRKAR1A | ++ | Thyroid | Myxomas of skin and heart | |
Familial Adenomatous Polyposis | + | + | - | + | +/- | - | + | APC | - | Adenoma+++ | Colon, brain | Desmoid tumors, osteomas |
Hereditary Non-Polyposis Colon Cancer | - | + | - | + | +/- | - | + | MLH1
MSH2 MSH3 MSH6 PMS1 PMS2 |
- | Adenoma+ | Endometrial, gastric, renal pelvis, ureter, and ovarian | Sebaceous adenoma |
|
References
- ↑ Buck, J L; Harned, R K; Lichtenstein, J E; Sobin, L H (1992). "Peutz-Jeghers syndrome". RadioGraphics. 12 (2): 365–378. doi:10.1148/radiographics.12.2.1561426. ISSN 0271-5333.